Literature DB >> 10739828

Study of apoptotic DNA fragmentation in human spermatozoa.

L Gandini1, F Lombardo, D Paoli, L Caponecchia, G Familiari, C Verlengia, F Dondero, A Lenzi.   

Abstract

The aim of our work was to define and better understand apoptosis in the spermatozoa of normal subjects, infertile patients and patients affected by specific tumoral diseases employing the method of the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling and confirming the results by electron microscopy. We studied 23 healthy, normozoospermic subjects (group A), 29 oligoasthenoteratozoospermic patients, affected by various andrological pathologies (group B), 28 patients with Hodgkin's disease (C1) and 30 patients with testicular cancer (C2). Our data demonstrate that the percentage of apoptosis in normozoospermic subjects (group A) is significantly lower than in all the other groups (B, C1, C2) (P < 0.001). This confirms that high DNA fragmentation is one of the characteristics of spermatogenetic failure. The induction of apoptosis, which can also be a basic response to neoplastic disease, can even act right up to the mature male gamete. Our results suggest that apoptosis could be the final result of various pathologies and of a deregulation of spermatogenesis control systems.

Entities:  

Mesh:

Year:  2000        PMID: 10739828     DOI: 10.1093/humrep/15.4.830

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  44 in total

1.  Effects of the crude extract of Polygala tenuifolia Willd on human sperm in vitro.

Authors:  Yi Qiu; Lei-guang Wang; Yi-fang Jia; Dan-tong Yang; Mei-hua Zhang; Yan-ping Zhang; Li-hong Zhang; Ling Gai
Journal:  J Zhejiang Univ Sci B       Date:  2011-06       Impact factor: 3.066

Review 2.  Effects of cancer and anti-neoplastic treatment on the human testicular function.

Authors:  A De Palma; E Vicari; I Palermo; R D'Agata; A E Calogero
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

Review 3.  The role of the medical andrologist in the assisted reproduction era.

Authors:  A Lenzi
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

Review 4.  Measurement and significance of sperm morphology.

Authors:  Roelof Menkveld; Cas A G Holleboom; Johann P T Rhemrev
Journal:  Asian J Androl       Date:  2010-11-15       Impact factor: 3.285

5.  Human sperm sex chromosome disomy and sperm DNA damage assessed by the neutral comet assay.

Authors:  M E McAuliffe; P L Williams; S A Korrick; R Dadd; F Marchetti; S E Martenies; M J Perry
Journal:  Hum Reprod       Date:  2014-07-27       Impact factor: 6.918

6.  Lower sperm DNA fragmentation after r-FSH administration in functional hypogonadotropic hypogonadism.

Authors:  Giovanni Ruvolo; Maria Carmela Roccheri; Anna Maria Brucculeri; Salvatore Longobardi; Ettore Cittadini; Liana Bosco
Journal:  J Assist Reprod Genet       Date:  2013-02-24       Impact factor: 3.412

7.  Effects of sera taken from women with recurrent spontaneous abortion on sperm motility and apoptosis.

Authors:  Tahereh Talaei-Khozani; Zahra Borzoei; Soghra Bahmanpour; Jaleh Zolghadr; Sedigheh Dehbashi; Hamid Reza Zareh
Journal:  Iran J Reprod Med       Date:  2011

8.  Effect of the oral intake of astaxanthin on semen parameters in patients with oligo-astheno-teratozoospermia: a randomized double-blind placebo-controlled trial.

Authors:  Senka Imamovic Kumalic; Irma Virant Klun; Eda Vrtacnik Bokal; Bojana Pinter
Journal:  Radiol Oncol       Date:  2020-10-23       Impact factor: 2.991

Review 9.  Sperm DNA damage in male infertility: etiologies, assays, and outcomes.

Authors:  Ryan T Schulte; Dana A Ohl; Mark Sigman; Gary D Smith
Journal:  J Assist Reprod Genet       Date:  2009-12-12       Impact factor: 3.412

10.  Caspase signalling pathways in human spermatogenesis.

Authors:  Carolina Almeida; Sofia Correia; Eduardo Rocha; Angela Alves; Luís Ferraz; Joquina Silva; Mário Sousa; Alberto Barros
Journal:  J Assist Reprod Genet       Date:  2013-01-29       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.